Found: 6
Select item for more details and to access through your institution.
2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. 1, doi. 10.1186/s13046-020-01608-9
- By:
- Publication type:
- Article
Lapachol is a novel ribosomal protein S6 kinase 2 inhibitor that suppresses growth and induces intrinsic apoptosis in esophageal squamous cell carcinoma cells.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Gossypin inhibits gastric cancer growth by direct targeting of AURKA and RSK2.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Purpurogallin is a novel mitogen‐activated protein kinase kinase 1/2 inhibitor that suppresses esophageal squamous cell carcinoma growth in vitro and in vivo.
- Published in:
- Molecular Carcinogenesis, 2019, v. 58, n. 7, p. 1248, doi. 10.1002/mc.23007
- By:
- Publication type:
- Article
Ethyl gallate as a novel ERK1/2 inhibitor suppresses patient‐derived esophageal tumor growth.
- Published in:
- Molecular Carcinogenesis, 2019, v. 58, n. 4, p. 533, doi. 10.1002/mc.22948
- By:
- Publication type:
- Article
Homodimerized cytoplasmic domain of PD-L1 regulates its complex glycosylation in living cells.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-03845-4
- By:
- Publication type:
- Article